v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   81,850,000      
Beginning balance at Dec. 31, 2024 $ 66,927 $ 8 $ 629,673 $ 52 $ (562,806)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 339,142 339,000      
Issuance of common stock upon exercise of stock options $ 1,049   1,049    
Issuance of common stock upon release of stock awards (in shares)   652,000      
Stock-based compensation 2,379   2,379    
Net loss (20,688)       (20,688)
Other comprehensive loss (38)     (38)  
Ending balance (in shares) at Mar. 31, 2025   82,841,000      
Ending balance at Mar. 31, 2025 49,629 $ 8 633,101 14 (583,494)
Beginning balance (in shares) at Dec. 31, 2025   90,478,000      
Beginning balance at Dec. 31, 2025 $ 50,529 $ 9 657,292 8 (606,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 0        
Issuance of common stock upon release of stock awards (in shares)   416,000      
Stock-based compensation $ 1,428   1,428    
Net loss (8,704)       (8,704)
Other comprehensive loss (19)     (19)  
Ending balance (in shares) at Mar. 31, 2026   90,894,000      
Ending balance at Mar. 31, 2026 $ 43,234 $ 9 $ 658,720 $ (11) $ (615,484)